SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: S-1/A
Date Filed: 2026-03-18
Accession Number: 0001493152-26-010642
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226010642/forms-1a.htm

Chunk 84 of 85
Word Count: 335
Character Count: 2159

Document Content:

is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. 7. The undersigned registrant hereby undertakes that: a. For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

b.	For
the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.

SIGNATURES

Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the Town of Mansfield, Commonwealth of Massachusetts, on March 17, 2026.

BioVentrix,
Inc.

David Richmond

Name:	David
Richmond

Title:	Co-Chief
Executive Officer

Signature Title Date

/s/ David Richmond Chairman of the Board, Co-Chief Executive Officer and Chief Financial Officer March 17, 2026

David Richmond (Principal Executive Officer, Principal Accounting Officer and Principal Financial Officer)

/s/ Steven Chartier Co-Chief Executive Officer, President and Director March 17, 2026

Steven Chartier

/s/ Mark Ravich Director March 17, 2026

Mark Ravich

/s/ Rishi Puri Director March 17, 2026

Rishi Puri

/s/ William Abraham Director March 17, 2026

William Abraham